BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20130066)

  • 1. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
    Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
    J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.
    Pan CH; Valsamakis A; Colella T; Nair N; Adams RJ; Polack FP; Greer CE; Perri S; Polo JM; Griffin DE
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11581-8. PubMed ID: 16037211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.
    Polack FP; Lydy SL; Lee SH; Rota PA; Bellini WJ; Adams RJ; Robinson HL; Griffin DE
    Clin Vaccine Immunol; 2013 Feb; 20(2):205-10. PubMed ID: 23239799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins.
    Lin WH; Vilalta A; Adams RJ; Rolland A; Sullivan SM; Griffin DE
    J Virol; 2013 Jun; 87(12):6560-8. PubMed ID: 23552419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus.
    Pan CH; Jimenez GS; Nair N; Wei Q; Adams RJ; Polack FP; Rolland A; Vilalta A; Griffin DE
    Clin Vaccine Immunol; 2008 Aug; 15(8):1214-21. PubMed ID: 18524884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
    Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
    J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice.
    Bergen MJ; Pan CH; Greer CE; Legg HS; Polo JM; Griffin DE
    PLoS One; 2010 Apr; 5(4):e10297. PubMed ID: 20421972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
    Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
    J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced measles virus-specific T cells do not prevent infection or disease but facilitate subsequent clearance of viral RNA.
    Lin WH; Pan CH; Adams RJ; Laube BL; Griffin DE
    mBio; 2014 Apr; 5(2):e01047. PubMed ID: 24736226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
    Zhu Yd; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
    Virology; 2000 Oct; 276(1):202-13. PubMed ID: 11022008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity.
    Pasetti MF; Ramirez K; Resendiz-Albor A; Ulmer J; Barry EM; Levine MM
    J Virol; 2009 Mar; 83(6):2789-94. PubMed ID: 19129445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.
    Pan CH; Nair N; Adams RJ; Zink MC; Lee EY; Polack FP; Singh M; O'Hagan DT; Griffin DE
    Clin Vaccine Immunol; 2008 Apr; 15(4):697-706. PubMed ID: 18287579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
    Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
    J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
    Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
    J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
    Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
    Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques.
    Pasetti MF; Resendiz-Albor A; Ramirez K; Stout R; Papania M; Adams RJ; Polack FP; Ward BJ; Burt D; Chabot S; Ulmer J; Barry EM; Levine MM
    Clin Pharmacol Ther; 2007 Dec; 82(6):672-85. PubMed ID: 17971812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant.
    Barnett SW; Burke B; Sun Y; Kan E; Legg H; Lian Y; Bost K; Zhou F; Goodsell A; Zur Megede J; Polo J; Donnelly J; Ulmer J; Otten GR; Miller CJ; Vajdy M; Srivastava IK
    J Virol; 2010 Jun; 84(12):5975-85. PubMed ID: 20392857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.
    Durbin AP; Skiadopoulos MH; McAuliffe JM; Riggs JM; Surman SR; Collins PL; Murphy BR
    J Virol; 2000 Aug; 74(15):6821-31. PubMed ID: 10888621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
    Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
    J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.